Tenofovir Alafenamide is an antiviral medication used to treat chronic hepatitis B virus (HBV) infection in adults with compensated liver disease. It works by inhibiting HBV replication, thereby reducing viral load and preventing liver damage. Tenofovir Alafenamide is a newer formulation that offers improved safety and efficacy compared to older treatments. In summary, Tenofovir Alafenamide is vital for managing chronic hepatitis B infections.
Tenofovir Alafenamide inhibits HBV reverse transcriptase, leading to termination of viral DNA synthesis and reduced viral replication.